Today on Concierge For Better Living we are joined by Strainprint's VP of Research, Michelle Arbus. Michelle is a veteran of the market research industry with over a decade of experience at the global research firms Ipsos and the NPD Group. While at these organizations, she conducted rigorous data analysis which provided multi-national corporations with data-driven insights and recommendations to solve their business issues. Most recently, Michelle took her analytical expertise to the Ontario Ministry of Health where she consulted on issues such as cannabis, tobacco smoking, routine childhood immunizations, and the flu. She led research which was used as the basis for the strategic direction of programs, initiatives or communications on various health matters. Michelle will be in charge of heading up research efforts at Strainprint, including doing a deep-dive on the rich, 7 million data-points, analyzing the data and creating meaningful reports. Michelle holds a BA Honours in Psychology from York University and an MBA from Dalhousie University.
Founded in Toronto in 2016, StrainprintTM Technologies Ltd. is the leading demand-side cannabis data and analytics company. With the world's largest longitudinal, observational data-set of its kind and a mission to advance the scientific understanding of cannabis and its legitimization as a mainstream therapy, Strainprint helps medical cannabis patients and doctors to use cannabis in the most effective and responsible way possible. StrainprintTM data platform supports global cannabis research and provides advanced business intelligence and treatment guidance to producers, retailers, medical practitioners, pharmacies, government, and industry. Strainprint is HIPAA, PIPEDA and PHIPA privacy compliant, military-grade encrypted and all patient data is completely anonymized and at rest in Canada. Strainprint can be seamlessly embedded or integrated with most electronic medical records (EMR) and seed2sale software systems. Strainprint Analytics is accessed by customer subscription.